A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
- Submitting institution
-
The University of Sheffield
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 7609
- Type
- D - Journal article
- DOI
-
10.1016/j.jtho.2020.06.011
- Title of journal
- Journal of Thoracic Oncology
- Article number
- -
- First page
- 1647
- Volume
- 15
- Issue
- 10
- ISSN
- 1556-0864
- Open access status
- Compliant
- Month of publication
- June
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
37
- Research group(s)
-
B - Cancer
- Citation count
- 4
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author is the lead/corresponding author.
- Non-English
- No
- English abstract
- -
